文献速递放疗物理与技术姑息放疗与转移瘤

单次立体定向放疗根治性治疗颅外原发肿瘤的系统综述

Efficacy and safety of single-fraction stereotactic body radiotherapy (SBRT) for the curative treatment of extracranial primary Tumors: A collaborative systematic review on behalf of the SBRT Focus Group of the European Society for Radiotherapy & Oncology (ESTRO).
PubMed 文献 · Clin Transl Radiat Oncol · 2026-10-01

本系统综述由ESTRO SBRT焦点组联合多个疾病部位焦点组完成,汇总单次立体定向体部放疗(SF-SBRT)根治性治疗主要颅外原发肿瘤的现有证据。结果显示,在特定解剖部位SF-SBRT安全有效,但强调谨慎选择患者及治疗计划与实施的技术要求。

要点

  • SF-SBRT在特定颅外原发肿瘤部位显示安全有效
  • 患者选择与治疗计划实施的技术要求至关重要
  • 需通过未来临床试验填补关键知识空白

核心结论

  • 对于特定解剖部位,单次立体定向体部放疗(SF-SBRT)根治性治疗颅外原发肿瘤安全有效。

研究设计与样本

  • 由ESTRO SBRT焦点组联合多个疾病部位焦点组成员共同完成的协作性系统综述。

主要发现

  • SF-SBRT在特定解剖部位安全有效,但结果强调谨慎选择患者及治疗计划与实施的技术要求。

临床怎么用

  • 在特定解剖部位可考虑SF-SBRT根治性治疗,但须严格选择患者并满足治疗计划与实施的技术要求。

局限性

  • 本综述识别了当前证据的关键知识空白,需未来研究及临床试验进一步探讨。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Single-fraction stereotactic body radiotherapy (SF-SBRT) represents one of the most advanced frontiers in modern radiation oncology. While ultra-hypofractionation has entered everyday clinical practice in different fields of the oncological care, curative treatments in one session are increasingly attractive for the potential favorable combination of logistic advantages with safety and clinical outcomes. This collaborative systematic review promoted by the ESTRO SBRT Focus Group in participation with members of different disease-site Focus Groups collects the available data in support of SF-SBRT for the curative treatment of the main extracranial primary tumors. The findings highlight that, for specific anatomical sites, SF-SBRT is both safe and effective though the results emphasize the critical importance of careful patient selection and mandatory technological requirements for treatment planning and delivery. This collaborative work provides a comprehensive overview of current evidence and identifies key knowledge gaps for future investigation and upcoming clinical trials.

来源:Clin Transl Radiat Oncol,查看原文。版权归原作者所有。

引用

  1. Cuccia F, Franzese C, Dubash S, et al. Efficacy and safety of single-fraction stereotactic body radiotherapy (SBRT) for the curative treatment of extracranial primary Tumors: A collaborative systematic review on behalf of the SBRT Focus Group of the European Society for Radiotherapy & Oncology (ESTRO). Clin Transl Radiat Oncol. 2026. PMID: 42898625. doi:10.1016/j.ctro.2026.101295

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。